Black children with severe pain are less likely to receive opioids in emergency rooms than white children.
Hospital
Advertisement
The placebo effect is growing stronger in US clinical trials for chronic pain medications.
Advertisement
Citing a rare yet serious risk of slowed breathing, the FDA is evaluating the use of the opioid pain medication tramadol (Ultram, Ultram ER, Conzip) in the pediatric population.
Gabapentin Differs From Pregabalin in Several Key Ways
Published: | Updated:
Pregabalin and gabapentin are often considered first-line treatments for various neuropathic pain syndromes, generally irrespective of cause.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Clears First Single-Inhaler Triple Therapy for Asthma
2
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
3
FDA Clears the Way for First Generic Single-Dose Flu Treatment Ahead of 2026 Season
4
Elevating Precision Medicine in Breast Cancer Care
5